New device aims to filter toxins in liver crisis

This study tests whether adding the CytoSorb blood-filtering device to standard hospital care can better remove waste products like bilirubin and ammonia in people with sudden worsening of chronic liver disease. Twenty adults with severe liver failure will receive the device for 72 hours, and their outcomes will be compared to a similar group from the past who got standard care alone. The goal is to see if the device can reduce liver toxins and improve brain function during this critical illness.